Invention Grant
US08088779B2 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists 有权
可用作促肾上腺皮质激素释放因子(CRF)受体拮抗剂的吡唑并[1,5-a]嘧啶基衍生物

  • Patent Title: Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
  • Patent Title (中): 可用作促肾上腺皮质激素释放因子(CRF)受体拮抗剂的吡唑并[1,5-a]嘧啶基衍生物
  • Application No.: US12067939
    Application Date: 2006-09-28
  • Publication No.: US08088779B2
    Publication Date: 2012-01-03
  • Inventor: Frank Hossner
  • Applicant: Frank Hossner
  • Applicant Address: IE Currabinny, Carrigaline, County Cork
  • Assignee: SmithKline Beecham (Cork) Limited
  • Current Assignee: SmithKline Beecham (Cork) Limited
  • Current Assignee Address: IE Currabinny, Carrigaline, County Cork
  • Agent Bonnie L. Deppenbrock
  • Priority: GB0519957.5 20050930; WOPCT/US2005/037576 20051019
  • International Application: PCT/EP2006/009531 WO 20060928
  • International Announcement: WO2007/039264 WO 20070412
  • Main IPC: A01N43/90
  • IPC: A01N43/90 A61K31/519 C07D487/00
Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
Abstract:
The present invention generally relates to the polymorph Form 2 of [3-(4-methoxy-2-methyl-phenyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-[(S)-1-(3-methyl-[1,2,4]oxa-diazol-5-yl)-propyl]amine. The present invention also relates to pharmaceutical compositions comprising the same and methods of using the same.
Information query
Patent Agency Ranking
0/0